Skip to main content
Clinical Trials/ISRCTN54477575
ISRCTN54477575
Completed
未知

Investigating childhood hip diseases (Slipped capital femoral epiphysis and Perthes’ disease) as childhood precursors to osteoarthritis of the hip in adulthood: A nationwide anonymised surveillance cohort, and nested-consented cohort study

niversity of Liverpool0 sites857 target enrollmentApril 19, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Slipped capital femoral epiphysis (SCFE), Perthes' disease
Sponsor
niversity of Liverpool
Enrollment
857
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

2020 Protocol article in https://doi.org/10.1302/2046-3758.13.BJO-2020-0002 SCFE protocol (added 12/05/2020) 2020 Protocol article in https://doi.org/10.1302/2046-3758.13.BJO-2020-0008 protocol (added 12/05/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35360941/ Perthes' disease epidemiology and two-year outcomes (added 04/04/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35360942/ slipped capital femoral epiphysis epidemiology and two-year outcomes (added 04/04/2022)

Registry
who.int
Start Date
April 19, 2017
End Date
March 1, 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Liverpool

Eligibility Criteria

Inclusion Criteria

  • 1\.Skeletally immature individuals
  • 2\. Radiological confirmation of displacement of the epiphysis relative to the metaphysis occurring at the proximal femoral physis
  • 3\. Newly presenting to secondary/ tertiary care during the study period with the above radiographic changes in either hip (i.e. patients will be included if the other side has been affected outside the study period, but the opposite hip is newly affected)
  • 4\. Undergoing surgical stabilisation during hospital admission
  • 5\. Resident within the England, Scotland or Wales
  • 1\. Skeletally immature individuals.
  • 2\. Any of the following radiographic features within the femoral epiphysis. Features may be evident on plain radiographs, or MRI.
  • 2\.1\. Flattening
  • 2\.2\. Sclerosis
  • 2\.3\. Fragmentation

Exclusion Criteria

  • Previous attempts at stabilisation of the currently affected hip.
  • 1\. Previous treatment for developmental hip dysplasia (not including double nappies)
  • 2\. Previous chemotherapy for malignancy
  • 3\. Previously diagnosed sickle cell anaemia
  • 4\. Multiple Epiphyseal Dysplasia (MED) or Spondyloepiphyseal Dysplasia (SED).
  • 5\. A known coagulopathy
  • 6\. Gauchers disease
  • 7\. Previous same\-sided hip fracture
  • 8\. Hypothyroidism

Outcomes

Primary Outcomes

Not specified

Similar Trials